A simple and sensitive validated HPLC method for quantitative determination of cisplatin in human plasma
- 21 January 2010
- journal article
- research article
- Published by Taylor & Francis in Clinical Research and Regulatory Affairs
- Vol. 27 (1) , 1-6
Abstract
Cisplatin is an anti-tumor agent widely employed in cancer chemotherapy. A specific and selective method for the quantitative determination of cisplatin in human plasma and its applications to pharmacokinetic investigations is described. One simple ethanol-induced protein precipitation step followed by simple liquid–liquid extraction with chloroform is the only requirement as sample treatment. The resulting solution is injected into a Wakosil II (5 μm, 250 cm × 4.6 mm I.D.) analytical column. The mobile phase consisted of methanol:water:acetonitrile (40:30:30 v/v/v). The limit of quantitation was 1 μg/mL. The method showed good recovery (93.95%) and within batch recovery was 91.59–97.00%. At all levels intra- and inter-assay precision was lower than 7 and 10%, respectively. The intra- and inter-assay accuracy ranged from −2.7 to 2% and from −3.1 to 4.0%, respectively. The selectivity (discrimination between the parent drug and platinum containing species such as cisplatin metabolites), simplicity and speed of this assay for free cisplatin quantitation should facilitate pharmacokinetic investigations and therapeutic drug monitoring.Keywords
This publication has 13 references indexed in Scilit:
- Population pharmacokinetics of cisplatin in Asian Indian cancer patientsClinical Research and Regulatory Affairs, 2009
- Simple and rapid determination of carboplatin in plasma by high-performance liquid chromatography. Error pattern and application to clinical pharmacokinetic studiesJournal of Chromatography B: Biomedical Sciences and Applications, 2001
- Comparison of ethanol plasma-protein precipitation with plasma ultrafiltration and trichloroacetic acid protein precipitation for the measurement of unbound platinum concentrationsCancer Chemotherapy and Pharmacology, 1996
- A Sensitive Postcolumn Derivatization/UV Detection System for HPLC Determination of Antitumor Divalent and Quadrivalent Platinum Complexes.Chemical and Pharmaceutical Bulletin, 1995
- The application of renal cells in culture in studying drug-induced nephrotoxicityIn Vitro Cellular & Developmental Biology, 1989
- Pharmacokinetics of unchanged carboplatin (CBDCA) in patients with small cell lung carcinomaCancer Chemotherapy and Pharmacology, 1987
- Uptake and metabolism of cisplatin by rat kidneyKidney International, 1984
- Postcolumn reaction detector for platinum(II) antineoplastic agentsAnalytical Chemistry, 1984
- HPLC Analysis of Cisplatin Analogues in Biological Fluids1984
- Analysis of platinum complexes by liquid chromatogrphy with quenched phosphrescence detectionJournal of Chromatography A, 1984